About BB MEDTECH
In mid-August 2009 an overwhelming majority of the shareholders of BB MEDTECH AG, Schaffhausen, backed the proposal to transform the listed investment company into a Luxembourg-based equity fund. According to the final tally, 94.97% of all outstanding shares were tendered. The newly created BB Medtech (Lux) Fund offers shareholders a transparent and highly liquid investment vehicle that, like its predecessor, will invest in listed companies active in the fast growing medical technology market.
The BB Medtech (Lux) Fund was launched as scheduled on September 28 as a sub-fund within the Bellevue Funds (Lux) SICAV. The existing shareholders of BB MEDTECH AG were allocated 1 fund unit per share tendered on October 2, 2009. Subscription and redemption orders can be submitted every trading day through your bank or securities trader. Net Asset Value is calculated on a daily basis and published under the following link and on independent financial information platforms.
The BB Medtech (Lux) Fund is the latest addition to Bellevue Asset Management's family of Luxembourg-based funds in the healthcare segment. Bellevue Asset Management, an independent, highly specialized asset management boutique with a more than 15-year track record and CHF 2.7 billion in assets under management, ranks among the leading providers of investment services in this sector.
Information on payment and settlement instructions for banks
